Hormone Sensitive Prostate Cancer Market size and Key Trends in terms of volume and value 2016-2026

fmiresearch

Prostate cancer is a general term used for diseased condition in which abnormal cells grow and invade in uncontrolled manner in the prostate. Prostate cancer inhibits production of male sex hormones (i.e. androgens) and ultimately blocks the action of androgen. The androgen is also responsible for the growth of prostate cancer. Androgen binds with the receptors and stimulates the expression of specific genes that would be responsible for prostate cancer. However, androgen suppression hormonal therapies are commonly used for the treatment of this cancer. These therapies acts by reducing the production of androgen by the testicles or by blocking the action of androgen in the body. There is an opportunity for the growth of hormone sensitive prostate cancer owing to the rapidly aging population which is the major cause of prostate cancer.

Hormone Sensitive

Prostate Cancer Market

Share, Global Trends,

Analysis, Research, Report,

Opportunities,

Segmentation and Forecast,

2016

Future Market Insights

www.futuremarketinsights.com

sales@futuremarketinsights.com


Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting

services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes,

technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends.

We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC.

Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and

Retail.

We have a global presence with delivery centers across India specializing in providing global research reports and country

research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India.

We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for

our client.

Research Capabilities

• Customized Research

• Syndicated Research

• Investment Research

• Social Media Research

Sector Coverage

• Automotive and Transportation

• Electronics, Semiconductor, and ICT

• Retail and Consumer Products

• Industrial Automation and Equipment

• Chemicals & Materials

• Food and Beverages

• Services and Utilities

• Energy, Mining, Oil, and Gas

Customized

Research

Syndicated

Research

Investment

Research

Social Media

Research

Subscription Information

For detailed subscription information please contact

Hari. T (Sr. Manager - Global Business Development)

T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268

Email: hari.t@futuremarketinsights.com


Report Description

Prostate cancer is a general term used for diseased condition in which abnormal cells

grow and invade in uncontrolled manner in the prostate. Prostate cancer inhibits

production of male sex hormones (i.e. androgens) and ultimately blocks the action of

androgen. The androgen is also responsible for the growth of prostate cancer. Androgen

binds with the receptors and stimulates the expression of specific genes that would be

responsible for prostate cancer. However, androgen suppression hormonal therapies are

commonly used for the treatment of this cancer. These therapies acts by reducing the

production of androgen by the testicles or by blocking the action of androgen in the

body. There is an opportunity for the growth of hormone sensitive prostate cancer owing

to the rapidly aging population which is the major cause of prostate cancer.

Hormone Sensitive Prostate Cancer Market: Drivers and Restraints

Increasing incidence of hormone sensitive prostate cancers and availability of various

treatment modalities like surgery, radiation therapy and cryosurgery are the major factors

driving the growth of hormone sensitive prostate cancer treatment market globally. The

driving factor of hormone sensitive prostate cancer market is the. Advancement in

technology, personalized medicine, cost effective treatment procedures are few other

factors expected provide boost to global hormone sensitive prostate cancer treatment

market. However, limited commercially availability drugs and treatments for this cancer is

the challenge restraining the growth of global hormone sensitive prostate cancer

treatment market.


Report Description

Request free sample Report: http://www.futuremarketinsights.com/reports/sample/repgb-1375

Hormone Sensitive Prostate Cancer Market: Segmentation

The global hormone sensitive prostate cancer market has been segmented on the basis

of treatment, end use and geography.

Based on treatment, the global hormone sensitive prostate cancer market is segmented

into:

• Androgen Ablation Therapy

• Anti-androgens

• Chemotherapy

• Targeted Therapy

• Cryotherapy

Based on end user type, the global hormone sensitive prostate cancer market is

segmented into:

• Hospitals

• Clinics

Cancer Rehabilitation Centers


Report Description

Request for TOC: http://www.futuremarketinsights.com/toc/rep-gb-1375

Hormone Sensitive Prostate Cancer Market: Regional Overview

Geographically, the global hormone sensitive prostate cancer market is classified into

regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-

Pacific, Japan, Middle East and Africa.North America takes the largest share of global

hormone sensitive cancer treatment market followed by Europe. The global hormone

sensitive prostate cancer treatment market is expected to grow in future due to

increasing investment by multinational companies in cancer research.

Hormone Sensitive Prostate Cancer Market: Key Players

Some of the key players in hormone sensitive prostate cancer market are Novartis

Pharmaceuticals, Merc & Co., Inc., Bristol-Myers, Dendreon Corporation, GlaxoSmithKline

plc., Ferring International Center S.A., Roche group, Celgen Corporation, Amgen Inc., Teva

pharmaceutical Industries Ltd., Bayer AG, and Pfizer Inc.

Browse full report: http://www.futuremarketinsights.com/reports/hormone-sensitiveprostate-cancer-market


Thank You!

To know more about us, please visit our website:

www.futuremarketinsights.com

For sales queries or new topics email us on:

sales@futuremarketinsights.com

For other queries contact: Mr. Sudip Saha

Future Market Insights: 616 Corporate Way, Suite 2-9018,

Valley Cottage, NY 10989, United States

T: +1-347-918-3531 | D: +1-845-579-5705

More magazines by this user
Similar magazines